Trxade Group Stock

Trxade Group EBIT

The EBIT of Trxade Group (MEDS) as of Aug 9, 2026 is -7.26 M USD. In the previous year, EBIT was -3.59 M USD — a change of 102.06% (lower).

EBIT

-7.26 MUSD

YoY

102.06%

Last updated:

In 2026, Trxade Group's EBIT was -7.26 M USD, a 102.06% increase from the -3.59 M USD EBIT recorded in the previous year.

The Trxade Group EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2018
-0.09 base
Jan 1, 2019
0.57 base
Jan 1, 2020
-2.51 base
Jan 1, 2021
-5.29 base
Jan 1, 2022
-3.59 base
Jan 1, 2023
-7.26 base
Jan 1, 2024 (e)
-0.89 base
Jan 1, 2025 (e)
4.77 base
YEAREBIT (M USD)
2025 est 4.77
2024 est -0.89
2023 -7.26
2022 -3.59
2021 -5.29
2020 -2.51
2019 0.57
2018 -0.09
2017 0.40
2016 -0.98
2015 -0.99
2014 -1.43
2013 -2.08
2012 -0.15
2008 -28.50
2007 -0.03
2006 -0.01
Access this data via the Eulerpool API

Trxade Group Revenue

Trxade Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
3.83 M USD
-87,616.00 USD
9,038.00 USD
Jan 1, 2019
7.44 M USD
565,819.00 USD
-409,730.00 USD
Jan 1, 2020
17.12 M USD
-2.51 M USD
-2.57 M USD
Jan 1, 2021
9.89 M USD
-5.29 M USD
-4.11 M USD
Jan 1, 2022
11.45 M USD
-3.59 M USD
-4.31 M USD
Jan 1, 2023
8.27 M USD
-7.26 M USD
-17.84 M USD
Jan 1, 2024 (e)
9.30 M USD
-887,400.00 USD
0.00 USD
Jan 1, 2025 (e)
27.11 M USD
4.77 M USD
13,108.58 USD

Trxade Group Margins

Trxade Group stock margins

The Trxade Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Trxade Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Trxade Group.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
88.28 %
-2.29 %
0.24 %
Jan 1, 2019
65.50 %
7.61 %
-5.51 %
Jan 1, 2020
33.33 %
-14.64 %
-14.98 %
Jan 1, 2021
47.99 %
-53.51 %
-41.59 %
Jan 1, 2022
47.62 %
-31.40 %
-37.65 %
Jan 1, 2023
31.41 %
-87.80 %
-215.70 %
Jan 1, 2024 (e)
31.41 %
-9.54 %
0.00 %
Jan 1, 2025 (e)
31.41 %
17.59 %
0.05 %

Trxade Group Stock analysis

What does Trxade Group do? The Trxade Group Inc is a US-American company that was founded in 2010 and has its headquarters in Tampa, Florida. The company is engaged in the development and operation of an online platform for trading pharmaceuticals and medical products for healthcare facilities and pharmacies. The business model of Trxade is to facilitate and streamline the purchase of pharmaceuticals and medical products for smaller healthcare facilities and pharmacies. To do this, the company operates an online platform that allows customers to order their needed products directly from various suppliers. By using the platform, customers can save time and costs as they no longer have to inquire with various suppliers and place individual orders for products. Instead, they can handle all their orders through the platform and thereby have access to a wider range of products and better prices. Trxade offers its customers various divisions. The main division is the trade of generic pharmaceuticals. Here, the company works closely with various suppliers and manufacturers to offer its customers a wide range of medications. Generic pharmaceuticals are usually cheaper than brand-name medications, allowing the company's customers to save costs. In addition, Trxade also offers other medical products such as vaccines, diagnostics, and medical accessories. Another business area of Trxade is the operation of pharmacies. The company operates several pharmacies under the brand name "Bonum Health," which offer a wide range of medical services. These include, for example, telehealth services, where patients can receive medical advice and assistance from licensed doctors via video call. The pharmacies also offer a wide range of prescription and over-the-counter medications. Trxade has undergone remarkable development in recent years. In 2016, the company went public and in 2019 had a revenue of around 10 million US dollars. Trxade now has over 11,000 registered customers and collaborates with over 450 suppliers and manufacturers. Overall, Trxade is an innovative company focused on simplifying and improving the trade of pharmaceuticals and medical products for smaller healthcare facilities and pharmacies. With its wide range of generic pharmaceuticals, medical accessories, and telehealth services, the company has established a strong position in the market and is expected to continue growing in the coming years. Trxade Group is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Trxade Group's EBIT

Trxade Group's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Trxade Group's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Trxade Group's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Trxade Group’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Trxade Group stock

EBIT of Trxade Group is -7.26 M USD in 2026.

EBIT of Trxade Group changed from -3.59 M USD to -7.26 M USD, representing a 102.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Trxade Group since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Trxade Group historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Trxade Group

All Key Metrics — Trxade Group